The largest purchase of all time was on 2015-08-14 and amounted to 126280 shares of Theravance Biopharma, Inc. for $1.49M.
The largest sale of all time was on 2013-04-30 and amounted to 255532 shares of Innoviva, Inc. for $8.6M.
No biography is available at this moment.
| 2023-08-14 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 1,241 0.0019% | $138.16 | $171,455 | -13.48% | |
| 2022-12-14 | Sale | Theravance Biopharma, Inc. TBPH | CHIEF EXECUTIVE OFFICER | 50,000 0.0741% | $11.19 | $559,500 | -7.4% | |
| 2022-08-05 | Sale | Jazz Pharmaceuticals plc JAZZ | 1,089 0.0017% | $152.32 | $165,879 | -6.46% | ||
| 2021-08-06 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 1,306 0.0021% | $147.96 | $193,236 | -4.99% | |
| 2020-08-07 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 931 0.0017% | $125.87 | $117,185 | +29.08% | |
| 2019-08-09 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 726 0.0013% | $135.65 | $98,482 | -9.37% | |
| 2018-08-10 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 660 0.0011% | $176.61 | $116,563 | -21.48% | |
| 2018-08-09 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 15,979 0.0262% | $176.16 | $2.81M | -22.18% | |
| 2017-08-11 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 662 0.0011% | $142.37 | $94,248 | +4.2% | |
| 2017-08-11 | Theravance Biopharma, Inc. TBPH | Chief Executive Officer | 20,000 0.0386% | $24.50 | $490,000 | +13.4% | ||
| 2017-06-01 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 5,000 0.0084% | $150.00 | $750,000 | -0.73% | |
| 2016-08-15 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 633 0.001% | $136.45 | $86,373 | -2.62% | |
| 2015-08-17 | Theravance Biopharma, Inc. TBPH | Chief Executive Officer | 33,720 0.1005% | $12.13 | $409,024 | +43.79% | ||
| 2015-08-14 | Theravance Biopharma, Inc. TBPH | Chief Executive Officer | 126,280 0.3701% | $11.79 | $1.49M | +44.97% | ||
| 2015-08-10 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 1,602 0.0026% | $180.00 | $288,355 | -22.09% | |
| 2014-08-12 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 2,174 0.0036% | $133.15 | $289,468 | +30.62% | |
| 2014-04-17 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 55,000 0.095% | $140.00 | $7.7M | +19.58% | |
| 2013-09-12 | Sale | Innoviva, Inc. INVA | Chief Executive Officer | 22,353 0.0271% | $40.03 | $894,791 | -15.02% | |
| 2013-08-13 | Sale | Jazz Pharmaceuticals plc JAZZ | director | 2,140 0.0037% | $81.86 | $175,180 | +65.54% | |
| 2013-04-30 | Sale | Innoviva, Inc. INVA | Chief Executive Officer | 255,532 0.3485% | $33.64 | $8.6M | +8% |